
Virginia Launches Treatment Atlas to Rate Addiction Care Quality
Virginia residents looking for addiction treatment can now compare providers on something other than how close they are. Treatment Atlas, a free online platform built by the national nonprofit Shatterproof with the Virginia Department of Social Services and the state's 211 helpline, went live on October 15, letting families sort programs by the care they actually deliver — insurance accepted, medications for opioid use disorder, evidence-based practices, the populations a program is set up to serve, and whether it helps with transportation.
The platform now sits alongside the state's existing helpline infrastructure, and the launch announcement framed it as an answer to a specific problem: the people making treatment decisions are usually making them in a crisis, with no way to tell a program's marketing from its medicine.
"Finding quality addiction treatment should not depend on guesswork," said Pam Jenkins, chief executive officer of Shatterproof. "Families are often forced to make treatment decisions during moments of crisis, yet it can be incredibly difficult to know which programs provide evidence-based care."
What the platform actually compares
Treatment Atlas is a directory with filters, not a referral service and not a bed registry. A user can search for providers and compare them across categories that the partnership says indicate quality: whether a program offers medication for opioid use disorder, which insurers it takes, whether it describes its approach as evidence-based, which specialty populations it serves, and indicators of accessibility such as transportation assistance. The platform is pitched at two audiences at once — people seeking care themselves, and the caseworkers, hospital discharge planners and helpline staff who route them.
That second audience is the reason the state is involved rather than just hosting a link. When someone calls 211 Virginia — the statewide information line for health and human services — a specialist can now pull up a comparable set of program details instead of working from a list of phone numbers.
"By integrating Treatment Atlas into 211 Virginia, we're creating a more accessible pathway to both community-based and clinical recovery resources," said Duke Storen, commissioner of the Virginia Department of Social Services. "Our commitment is to meet Virginians where they are, connect them to the resources they need, and help them move toward greater safety and independence."
Why quality data instead of bed counts
The partnership's stated premise is that not all addiction treatment is equivalent. Research has shown that programs do not consistently deliver evidence-based practices, and that the gap between what a facility advertises and what it does is hardest to see precisely when a family has the least time to investigate — which is why a comparison tool that sits outside the industry's own advertising is different from a search engine result.
The clearest example is medication for opioid use disorder, which federal agencies treat as the standard of care and which remains unevenly available across the country. A county-by-county bed count tells a caller nothing about whether buprenorphine, methadone or extended-release naltrexone is available on site; a filter that lists it program by program does. The same logic applies to whether a facility offers standard outpatient care or only residential beds, and to whether it will take a caller's specific insurance.
The platform also carries information for people already in the system. Jenkins described the design goal as a "'no wrong doors' approach," in which a consumer or a referral partner can navigate the treatment landscape without needing to know the vocabulary of levels of care in advance, and said recovery outcomes improve when people can find care that matches their needs and preferences.
What the launch leaves open
Virginia is not the first state to put treatment quality data in front of the public. New York City released a behavioral health provider directory in mid-October through its Mental Health Connect service, and Hawaii opened a statewide virtual intensive outpatient program earlier in the same week — a cluster of digital access tools that share an assumption that patients cannot use a system they cannot see into.
What Treatment Atlas does not yet carry is outcome data. The launch materials describe provider engagement, stakeholder education, community outreach and a public awareness campaign, including a stakeholder event in Richmond and a webinar for families and providers, but no measure of whether patients who use the platform stay in treatment longer or fare better than those who do not. The announcement also does not describe how program information will be verified or refreshed once it is listed — the maintenance question that determines how useful a comparison directory is a year from now.
For now the tool is a filter over a fragmented market, and its value will show up in what referral partners do with it. A helpline specialist who can rule out fourteen programs that do not accept a caller's insurance has saved that caller a morning of phone calls — a smaller claim than "better outcomes," but one that does not require a study to verify.
Sources
Editorial Board
Editorial review using SAMHSA, CDC, CMS, and state agency sources
The NWVCIL editorial team reviews and updates treatment-center information using public data from SAMHSA, CDC, CMS, and state behavioral-health agencies. We cross-check facility records, state coverage rules, and clinical-practice updates so the directory reflects current evidence and policy.
Related Articles

Wireless Microneedle Electroceutical Offers Non-Opioid Alternative for Chronic Pain Management
Nature Communications publishes breakthrough wireless microneedle device that delivers electrical stimulation for pain relief, offering non-opioid alternative for chronic pain management.

Arizona Launches AI-Powered Locator for Opioid Treatment Providers
Arizona's Medicaid agency AHCCCS debuts a GenAI locator built on Google's Gemini that connects residents to more than 100 vetted opioid treatment providers.

FDA Clears Drug Relief, a Neurostimulation Device to Ease Opioid Withdrawal Symptoms
DyAnsys Drug Relief receives FDA clearance as a non-narcotic auricular neurostimulation device designed to alleviate opioid withdrawal symptoms during detoxification.